The HERBY study: A phase II open label, randomized, multicenter, comparative study of bevacizumab (Bv)-based therapy in pediatric patients with newly diagnosed supratentorial high-grade glioma (HGG).
Jacques Grill
Consultant or Advisory Role - Roche
Honoraria - Roche
Darren R Hargrave
Consultant or Advisory Role - Roche
Expert Testimony - Roche (U)
Pascale Varlet
Consultant or Advisory Role - Roche
Research Funding - Roche
Expert Testimony - Roche
Tim Jaspan
Consultant or Advisory Role - Roche (U)
Chris Jones
Consultant or Advisory Role - Roche (U)
Research Funding - Roche/Genentech
Other Remuneration - Roche/Genentech
Maura Massimino
Consultant or Advisory Role - Roche
Honoraria - Roche
Adela Cañete
Consultant or Advisory Role - Roche
Amedeo A. Azizi
Consultant or Advisory Role - Roche
Marie-Cécile Le Deley
No relevant relationships to disclose
Frank Saran
Consultant or Advisory Role - Roche
Paul Morgan
Consultant or Advisory Role - Roche (U)
Gudrun Zahlmann
Employment or Leadership Position - Roche; Roche
Stock Ownership - Roche; Roche
Louis Viviers
No relevant relationships to disclose
Jeanette Bachir
No relevant relationships to disclose
Aijing Shang
Employment or Leadership Position - Roche
Stock Ownership - Roche
Raphael F. Rousseau
Employment or Leadership Position - Roche
Stock Ownership - Roche
Gilles Vassal
Research Funding - Roche